Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Exp Neurol. 2018 Oct 1;311:162–172. doi: 10.1016/j.expneurol.2018.09.016

Figure 5:

Figure 5:

Effect of post-stroke IGF-1 treatment on vinculin expression (A) 1d post stroke: Photomicrographs of vinculin immunostained representative sections from the ischemic cortex and striatum of control (i,ii), IGF-1 treated (iii,iv) and IGF-1+JB-1 treated (v,vi) animals. Histograms depict mean and SEM of the density of vinculin staining in each group in the ischemic and non-ischemic hemisphere. (B) 5d after stroke: Photomicrographs of vinculin immunostained representative sections from the ischemic cortex and striatum of control (i,ii), IGF-1 treated (iii,iv) and IGF-1+JB-1 treated (v,vi) animals. Histograms depict mean and SEM of the density of vinculin staining in each group in the ischemic and non-ischemic hemisphere. N = 4-6 in each group. *: p<0.05. Bar: 100 um